HuGE Literature Finder
Records
1
-
30
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort. Clinical lung cancer 2021 Aug . Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu |
| Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. Lung cancer (Amsterdam, Netherlands) 2021 Jul 159 66-73. Mondaca Sebastian, Lebow Emily S, Namakydoust Azadeh, Razavi Pedram, Reis-Filho Jorge S, Shen Ronglai, Offin Michael, Tu Hai-Yan, Murciano-Goroff Yonina, Xu Chongrui, Makhnin Alex, Martinez Andres, Pavlakis Nick, Clarke Stephen, Itchins Malinda, Lee Adrian, Rimner Andreas, Gomez Daniel, Rocco Gaetano, Chaft Jamie E, Riely Gregory J, Rudin Charles M, Jones David R, Li Mark, Shaffer Tristan, Hosseini Seyed Ali, Bertucci Caterina, Lim Lee P, Drilon Alexander, Berger Michael F, Benayed Ryma, Arcila Maria E, Isbell James M, Li Bob |
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathology, research and practice 2021 Jul 224 153551. Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| One-step polymerase chain reaction-free nanowire-based plasma cell-free DNA assay to detect EML4-ALK fusion and to monitor resistance in lung cancer. The oncologist 2021 Jul . Lee Youngjoo, Cho Youngnam, Park Eun Young, Park Seong-Yun, Hwang Kum Hui, Han Ji-Yo |
| Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis. Cancer treatment and research communications 2021 Jul 28 100440. Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Validation of the Novel IASLC Grading System for Invasive Pulmonary Adenocarcinoma and Association with Common Driver Mutations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Jul . Deng Chaoqiang, Zheng Qiang, Zhang Yang, Jin Yan, Shen Xuxia, Nie Xiao, Fu Fangqiu, Ma Xiangyi, Ma Zelin, Wen Zhexu, Wang Shengping, Li Yuan, Chen Haiqu |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-Analysis. JCO oncology practice 2021 May 17 (5): e629-e636. Costa Philippos A, Saul Eduardo E, Paul Yonette, Iyer Sunil, da Silva Laercio Lopes, Tamariz Leonardo, Lopes Gilber |
| Cell-Free Circulating Tumor DNA Improves Standard Genotyping of Non-Small-Cell Lung Cancer and Increases Detection of Targetable Alterations in a Selected Hispanic Cohort. Oncology 2021 Apr 1-8. Zatarain-Barrón Zyanya Lucia, Cardona Andrés F, Díaz-García Diego, Trejo Rosales Rogelio, Rojas Leonardo, Cruz-Rico Graciela, Nagy Rebecca, Cabrera Luis, Vargas Carlos, Saam Jennifer, Barrón Feliciano, Arrieta Osc |
| Implementation of clinical sequencing for molecular profiling in patients with advanced cancer. Cancer biomarkers : section A of Disease markers 2021 Apr . Fukui Tomoya, Sakai Kazuko, Sasaki Jiichiro, Kakegawa Mikiko Ishihara, Igawa Satoshi, Mitsufuji Hisashi, Takeda Masayuki, Takahama Takayuki, Nakagawa Kazuhiko, Nishio Kazuto, Naoki Katsuhi |
| Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer. Cancer medicine 2021 Apr 10 (7): 2216-2231. Shi Yunfei, Lei Youming, Liu Li, Zhang Shiyue, Wang Wenjing, Zhao Juan, Zhao Songhui, Dong Xiaowei, Yao Ming, Wang Kai, Zhou Qi |
| Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field. Lung cancer (Amsterdam, Netherlands) 2021 Apr 154 131-141. Volckmar Anna-Lena, Christopoulos Petros, Kirchner Martina, Allgäuer Michael, Neumann Olaf, Budczies Jan, Rempel Eugen, Horak Peter, Glade Julia, Goldschmid Hannah, Seker-Cin Huriye, Brandt Regine, Kriegsmann Mark, Leichsenring Jonas, Winter Hauke, Faehling Martin, Fischer Jürgen R, Heußel Claus Peter, Herth Felix, Brummer Tilman, Fröhling Stefan, Schirmacher Peter, Thomas Michael, Endris Volker, Penzel Roland, Kazdal Daniel, Bochtler Tilmann, Stenzinger Albrec |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| Crizotinib in Patients With MET-Amplified NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Mar . Camidge D Ross, Otterson Gregory A, Clark Jeffrey W, Ignatius Ou Sai-Hong, Weiss Jared, Ades Steven, Shapiro Geoffrey I, Socinski Mark A, Murphy Danielle A, Conte Umberto, Tang Yiyun, Wang Sherry C, Wilner Keith D, Villaruz Liza |
| Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL). BMJ open 2021 (3): e043234. Kagimoto Atsushi, Tsutani Yasuhiro, Mimae Takahiro, Miyata Yoshihiro, Ikeda Norihiko, Ito Hiroyuki, Maniwa Yoshimasa, Suzuki Kenji, Tsuboi Masahiro, Yoshimura Kenichi, Umemoto Seiji, Okada Morihi |
| Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort. BMC cancer 2021 Feb 21 (1): 176. Zhu Donglin, Cao Dan, Shen Minghong, Lv Jinghu |
| [A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2021 Jan . Zhang Hui, Yang Xinjie, Li Kun, Wang Jinghui, Lv Jialin, Li Xi, Zhang Xinyong, Qin Na, Zhang Quan, Wu Yuhua, Ma Li, Gai Fei, Hu Ying, Zhang Shuc |
| A population-based study of outcomes in patients with surgically resected non-small cell lung cancer with anaplastic lymphoma kinase-rearranged mutations: A matched-pair study. Molecular and clinical oncology 2021 Jan 14 (1): 11. Inagaki Masaharu, Ichimura Hideo, Usui Shingo, Iguchi Kesato, Ishibashi Osamu, Nakamura Ryota, Inage Yoshihisa, Suzuki Hisashi, Kiyoshima Moriyuki, Kamiyama Koichi, Kimura Masaki, Yoshida Susumu, Sakai Mitsuaki, Kobayashi Naohiro, Furukawa Kinya, Satoh Hiroaki, Hizawa Nobuyuki, Sato Yuk |
| Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score = 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Jan JCO2003579. Boyer Michael, Sendur Mehmet A N, Rodríguez-Abreu Delvys, Park Keunchil, Lee Dae Ho, Çiçin Irfan, Yumuk Perran Fulden, Orlandi Francisco J, Leal Ticiana A, Molinier Olivier, Soparattanapaisam Nopadol, Langleben Adrian, Califano Raffaele, Medgyasszay Balazs, Hsia Te-Chun, Otterson Gregory A, Xu Lu, Piperdi Bilal, Samkari Ayman, Reck Martin, |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma. OncoTargets and therapy 2021 14 2953-2965. Wang Hao, Chen Shanhao, Meng Die, Wu Chunyan, Zhu Junjie, Jiang Minlin, Ning Jing, Wu Shengyu, Wu Lijia, Li Jingjie, Chen Bin, Zhao Sha, Li Wei, Yu Jia, Fang Qiyu, Zhu Jun, Zhao Wencheng, He Yayi, Zhou Caic |
| Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418). Thoracic cancer 2020 Dec . Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, de Lima Vladmir Cordei |
| Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case Series. The Israel Medical Association journal : IMAJ 2020 Dec 22 (12): 784-787. Peled Michael, Bar Jair, Avni Liat, Chatterji Sumit, Somech Dafna, Dvir Addie, Soussan-Gutman Lior, Onn Am |
| The landscape of kinase domain duplication in Chinese lung cancer patients. Annals of translational medicine 2020 Dec 8 (24): 1642. Wu Di, Xie Yuancai, Jin Chang'e, Qiu Jinfan, Hou Ting, Du Haiwei, Chen Songan, Xiang Jianxing, Shi Xi, Liu Junli |
| Brigatinib in Japanese Patients With ALK-Positive NSCLC Previously Treated With Alectinib and Other Tyrosine Kinase Inhibitors: Outcomes of the Phase 2 J-ALTA Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Nov . Nishio Makoto, Yoshida Tatsuya, Kumagai Toru, Hida Toyoaki, Toyozawa Ryo, Shimokawaji Tadasuke, Goto Koichi, Nakagawa Kazuhiko, Ohe Yuichiro, Seto Takashi, Kudou Kentarou, Asato Takayuki, Zhang Pingkuan, Yamamoto Nobuyu |
| Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis. Annals of palliative medicine 2020 Nov 9 (6): 4233-4245. Miao Qian, Zheng Xiaobin, Zhang Longfeng, Jiang Kan, Wu Biao, Lin G |
| Lung Cancer in Bahrain: Histological and Molecular Features. The Gulf journal of oncology 2020 Sep 1 (34): 48-51. Mubarak Aalaa, Aljufairi Eman, Almahari Sayed A |
- Page last reviewed:Oct 1, 2021
- Page last updated:Oct 20, 2021
- Content source: